18 results on '"Mann, Kenneth G."'
Search Results
2. Rivaroxaban Delivery and Reversal at a Venous Flow Rate.
- Author
-
Haynes, Laura M., Orfeo, Thomas, and Mann, Kenneth G.
- Published
- 2012
- Full Text
- View/download PDF
3. Guided Antithrombotic Therapy: Current Status and Future Research Direction.
- Author
-
Fuster, Valentin, Bhatt, Deepak L., Califf, Robert M., Michelson, Alan D., Sabatine, Marc S., Angiolillo, Dominick J., Bates, Eric R., Cohen, David J., Coller, Barry S., Furie, Bruce, Hulot, Jean-Sebastien, Mann, Kenneth G., Mega, Jessica L., Musunuru, Kiran, O'Donnell, Christopher J., Price, Matthew J., Schneider, David J., Simon, Daniel I., Weitz, Jeffrey I., and Williams, Marlene S.
- Published
- 2012
- Full Text
- View/download PDF
4. Clotting Factor Deficiency in Early Trauma-Associated Coagulopathy.
- Author
-
Rizoli, Sandro B., Scarpelini, Sandro, Callum, Jeannie, Nascimento, Bartolomeu, Mann, Kenneth G., Pinto, Ruxandra, Jansen, Jan, and Tien, Homer C.
- Published
- 2011
- Full Text
- View/download PDF
5. Thrombin Generation in Hemorrhage Control and Vascular Occlusion.
- Author
-
Mann, Kenneth G.
- Subjects
- *
THROMBIN , *HEMORRHAGE , *FIBRIN , *BLOOD platelets , *BLOOD coagulation - Abstract
The article focuses on the generation of thrombin in hemorrhage control and vascular occlusion. It mentions the association of common molecular and cellular events with thrombin generation. It indicates that hemorrhage control results in the generation of a stable fibrin-platelet dam. It claims that thrombin functions both as a procoagulant and an anticoagulant.
- Published
- 2011
- Full Text
- View/download PDF
6. Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism.
- Author
-
Undas, Anetta, Sydor, Wojciech J, Brummel, Kathleen, Musial, Jacek, Mann, Kenneth G, and Szczeklik, Andrew
- Published
- 2003
7. Factor VII-activating protease: coagulation, fibrinolysis, and atherothrombosis?
- Author
-
Mann, Kenneth G
- Published
- 2003
8. Evidence of Estrogen Receptors in Normal Human Osteoblast-Like Cells.
- Author
-
ERIKSEN, ERIK F., COLVARD, DOUGLAS S., BERG, NICHOLAS J., GRAHAM, MARK L., MANN, KENNETH G., SPELSBERG, THOMAS C., and RlGGS, B. LAWRENCE
- Published
- 1989
- Full Text
- View/download PDF
9. Assessment of Coagulation Homeostasis in Blunt, Penetrating, and Thermal Trauma: Guidance for a Multicenter Systems Biology Approach.
- Author
-
Shupp JW, Brummel-Ziedins KE, Cohen MJ, Freeman K, Hammamieh R, Mudunuri US, Orfeo T, Moffatt LT, Brownstein BH, Mann KG, Jett M, and Pusateri AE
- Subjects
- Blood Coagulation physiology, Female, Homeostasis, Humans, Male, Multiple Trauma physiopathology, Prospective Studies, Multiple Trauma metabolism, Systems Biology methods
- Abstract
Introduction: Provisioning care for traumatically injured patients makes conducting research very proximal to injury difficult. These studies also inherently have regulatory barriers to overcome. Here we outline a protocol for acute-phase enrollment of traumatically injured patients into a prospective observational clinical trial with precise and comprehensive sample acquisition in support of a systems biology approach to a research study., Methods: Experts in trauma, burn, blood coagulation, computational biology, and integrative systems biology developed a prospective study that would capture the natural history of coagulation pathology after traumatic injury. Blood was sampled at admission and serial time points throughout hospitalization. Concurrently, demographic and outcomes data were recorded and on-site point-of-care testing was implemented. Protocols were harmonized across sites and sampling protocols validated through demonstration of feasibility and sample quality assurance testing. A novel data integration platform was developed to store, visualize, and enable large-scale analysis of empirical and clinical data. Regulatory considerations were also addressed in protocol development., Results: A comprehensive Manual of Operations (MOO) was developed and implemented at 3 clinical sites. After regulatory approval, the MOO was followed to collect 5,348 longitudinal samples from 1,547 patients. All samples were collected, processed, and stored per the MOO. Assay results and clinical data were entered into the novel data management platform for analyses., Conclusion: We used an iterative, interdisciplinary process to develop a systematic and robust protocol for comprehensive assessment of coagulation in traumatically injured patients. This MOO can be a template for future studies in the acute setting.
- Published
- 2019
- Full Text
- View/download PDF
10. Taking the thrombin "fork".
- Author
-
Mann KG
- Subjects
- Animals, Blood Coagulation Factors chemistry, Blood Coagulation Factors metabolism, History, 20th Century, History, 21st Century, Humans, Mentors, Protein Conformation, Structure-Activity Relationship, Thrombin chemistry, Thrombin metabolism, Biomedical Research history, Blood Coagulation, Blood Coagulation Factors history, Hematology history, Thrombin history
- Abstract
The proverb that probably best exemplifies my career in research is attributable to Yogi Berra (http://www.yogiberra.com/), ie, "when you come to a fork in the road ... take it." My career is a consequence of chance interactions with great mentors and talented students and the opportunities provided by a succession of ground-breaking improvements in technology.
- Published
- 2010
- Full Text
- View/download PDF
11. Tissue factor in coagulation: Which? Where? When?
- Author
-
Butenas S, Orfeo T, and Mann KG
- Subjects
- Cell Membrane metabolism, Humans, Models, Biological, Thromboplastin chemistry, Thromboplastin genetics, Blood Coagulation physiology, Thromboplastin physiology
- Abstract
Tissue factor (TF) is an integral membrane protein, normally separated from the blood by the vascular endothelium, which plays a key role in the initiation of blood coagulation. With a perforating vascular injury, TF becomes exposed to blood and binds plasma factor VIIa. The resulting complex initiates a series of enzymatic reactions leading to clot formation and vascular sealing. In some pathological states, circulating blood cells express TF as a result of exposure to an inflammatory stimulus leading to intravascular clotting, vessel occlusion, and thrombotic pathology. Numerous controversies have arisen related to the influence of structural features of TF, its presentation, and its function. There are contradictory reports about the synthesis and presentation of TF on blood cells and the presence (or absence) of functionally active TF circulating in normal blood either on microparticles or as a soluble protein. In this review we discuss TF structure-function relationships and the role of TF during various phases of the blood coagulation process. We also highlight controversies concerning the expression/presence of TF on various cells and in blood in normal and pathological states.
- Published
- 2009
- Full Text
- View/download PDF
12. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time.
- Author
-
Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, Kheirabadi BS, Pusateri AE, Vos JA, Guymon CH, Wolf SE, Mann KG, and Holcomb JB
- Subjects
- Adult, Antithrombin III analysis, Case-Control Studies, Factor XIa analysis, Female, Humans, Intensive Care Units, Male, Middle Aged, Partial Thromboplastin Time, Protein C analysis, Prothrombin Time, Pulmonary Embolism diagnosis, Pulmonary Embolism etiology, Venous Thromboembolism diagnosis, Venous Thromboembolism etiology, Thrombelastography, Thrombophilia diagnosis, Thrombophilia etiology, Wounds and Injuries complications
- Abstract
Objectives: To investigate the hemostatic status of critically ill, nonbleeding trauma patients. We hypothesized that a hypercoagulable state exists in patients early after severe injury and that the pattern of clotting and fibrinolysis are similar between burned and nonburn trauma patients., Materials: Patients admitted to the surgical or burn intensive care unit within 24 hours after injury were enrolled. Blood samples were drawn on days 0 through 7. Laboratory tests included prothrombin time (PT), activated partial thromboplastin time (aPTT), levels of activated factor XI, D-dimer, protein C percent activity, antithrombin III percent activity, and thromboelastography (TEG)., Results: Study subjects were enrolled from April 1, 2004, to May 31, 2005, and included nonburn trauma patients (n = 33), burned patients (n = 25), and healthy (control) subjects (n = 20). Despite aggressive thromboprophylaxis, three subjects (2 burned and 1 nonburn trauma patients [6%]) had pulmonary embolism during hospitalization. Compared with controls, all patients had prolonged PT and aPTT (p < 0.05). The rate of clot formation (alpha angle) and maximal clot strength were higher for patients compared with those of controls (p < 0.05), indicating a hypercoagulable state. Injured patients also had lower protein C and antithrombin III percent activities and higher fibrinogen levels (p < 0.05 for all). Activated factor XI was elevated in 38% of patients (control subjects had undetectable levels)., Discussion: Thromboelastography analysis of whole blood showed that patients were in a hypercoagulable state; this was not detected by plasma PT or aPTT. The high incidence of pulmonary embolism indicated that our current prophylaxis regimen could be improved.
- Published
- 2009
- Full Text
- View/download PDF
13. The resuscitative fluid you choose may potentiate bleeding.
- Author
-
Brummel-Ziedins K, Whelihan MF, Ziedins EG, and Mann KG
- Subjects
- Adult, Humans, In Vitro Techniques, Middle Aged, Resuscitation, Ringer's Lactate, Fibrinopeptide A metabolism, Hydroxyethyl Starch Derivatives pharmacology, Isotonic Solutions pharmacology, Plasma Substitutes pharmacology, Platelet Activation drug effects, Sodium Chloride pharmacology, Thrombin metabolism
- Abstract
Background: Trauma is the leading cause of death in the younger population in the United States, frequently from the development of hemorrhagic shock. Controversy exists over the type of volume resuscitation for restoring hemodynamic stability that should be used in hemorrhagic shock. Little is known about how various resuscitative paradigms affect the coagulation cascade, which is essential to controlling hemorrhagic shock., Methods: We studied the effect of various resuscitative formulas on blood coagulation using a new model of whole blood in a controlled setting with corn trypsin inhibitor and a 5-pM stimulus of tissue factor. We investigated thrombin generation, fibrin formation, and platelet activation with four diluents: 0.9% NaCl (NS), lactated Ringer's solution (LR), 6% hydroxyethyl starch (HES), and 3% NaCl (HS), each from 0% to 75% blood dilution. Thrombin generation was measured periodically during a time course of 20 minutes in its complex with antithrombin III. Platelet activation and fibrinopeptide A (FPA) release were monitored in serum at a 20-minute time point. Fibrin clots were collected and weighed., Results: The coagulation markers (thrombin generation, platelet activation, and FPA release) were significantly different by dilution (p < 0.001 in all) and diluent by dilution (p < 0.001 in all). Thrombin generation, platelet activation, and FPA release decreased the least with the diluents NS and LR. LR caused the least amount of variation in thrombin generation over the dilution course. HS produced the most dramatic change in all of the markers; no coagulation was seen between 30% to 75% dilution (p < 0.05). HES produced greater decreases in thrombin generation and FPA release than NS and LR. Fibrin clot mass decreased with a 10% to 20% dilution for NS and LR, whereas stable fibrin mass did not decrease with the diluents HES and HS at 10% to 20% dilutions. At >30% dilutions, HS produced no stable clots and HES dramatically decreased clot formation by 61% and maintained this level., Conclusions: LR and NS had the least effect on thrombin generation, clot formation, and platelet activation at various concentrations compared with HES and HS. This observational data suggests that volume expanders such as HES and HS may be detrimental in treatment of hemorrhagic shock.
- Published
- 2006
- Full Text
- View/download PDF
14. Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients.
- Author
-
Undas A, Celinska-Löwenhoff M, Brummel-Ziedins KE, Brozek J, Szczeklik A, and Mann KG
- Subjects
- Factor V metabolism, Factor Va metabolism, Humans, Hypercholesterolemia blood, Male, Middle Aged, Thrombin metabolism, Blood Coagulation drug effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors administration & dosage, Hypercholesterolemia drug therapy, Simvastatin administration & dosage
- Published
- 2005
- Full Text
- View/download PDF
15. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability.
- Author
-
Egorina EM, Sovershaev MA, Bjørkøy G, Gruber FX, Olsen JO, Parhami-Seren B, Mann KG, and Østerud B
- Subjects
- Blood Coagulation physiology, Gene Expression, Humans, In Vitro Techniques, Leukocytes, Mononuclear drug effects, Lipopolysaccharides pharmacology, Membrane Proteins metabolism, Tumor Necrosis Factor-alpha metabolism, Leukocytes, Mononuclear metabolism, Thromboplastin genetics, Thromboplastin metabolism, Thrombosis metabolism
- Abstract
Objective: The high and low responder phenomenon describes individual differences in lipopolysaccharide (LPS)-induced monocyte tissue factor (TF) activity. We characterized patterns of intracellular accumulation, externalization, and shedding of TF in response to LPS in mononuclear cells (MNCs) from high responders (HRs) and low responders (LRs)., Methods and Results: After 2 hours of LPS stimulation of whole blood, flow cytometry analyses revealed a larger population of TF-positive monocytes in HRs (32.0+/-3.5%) versus LRs (11.2+/-1.2%; P< or =0.05), along with a stronger mean fluorescence intensity of TF signal in HRs (7.1+/-0.5 arbitrary units [AU]) compared with LRs (5.4+/-0.4 AU; P< or =0.05). The LPS-treated blood of the HR group contained 2-fold more TF-positive microparticles than LRs. In-cell Western assay demonstrated higher intracellular accumulation of TF in mononuclear cells (MNCs) from LRs because LPS induced a 3.7-fold increase of total TF levels in LRs versus a 1.5-fold increase in HRs. In contrast, in response to LPS stimulation, MNCs from HRs exhibited a 4-fold induction of surface TF, whereas MNCs from LRs only had a minor increase in surface TF levels., Conclusions: The higher availability of surface TF antigen on MNCs from HRs and TF-containing microparticles might make these individuals more susceptible to hypercoagulation.
- Published
- 2005
- Full Text
- View/download PDF
16. Statins and blood coagulation.
- Author
-
Undas A, Brummel-Ziedins KE, and Mann KG
- Subjects
- Animals, Anticholesteremic Agents pharmacology, Anticholesteremic Agents therapeutic use, Anticoagulants pharmacology, Anticoagulants therapeutic use, Arteriosclerosis blood, Blood Coagulation Factors metabolism, Blood Proteins metabolism, Factor VII metabolism, Fibrinogen metabolism, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Models, Biological, Protein Prenylation drug effects, Staphylococcal Protein A metabolism, Thrombin biosynthesis, Thrombomodulin biosynthesis, Thrombophilia drug therapy, Thromboplastin biosynthesis, Venous Thrombosis drug therapy, Venous Thrombosis prevention & control, Blood Coagulation drug effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Protein Processing, Post-Translational drug effects, Thrombophilia prevention & control
- Abstract
The 3-hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase inhibitors (statins) have been shown to exhibit several vascular protective effects, including antithrombotic properties, that are not related to changes in lipid profile. There is growing evidence that treatment with statins can lead to a significant downregulation of the blood coagulation cascade, most probably as a result of decreased tissue factor expression, which leads to reduced thrombin generation. Accordingly, statin use has been associated with impairment of several coagulant reactions catalyzed by this enzyme. Moreover, evidence indicates that statins, via increased thrombomodulin expression on endothelial cells, may enhance the activity of the protein C anticoagulant pathway. Most of the antithrombotic effects of statins are attributed to the inhibition of isoprenylation of signaling proteins. These novel properties of statins, suggesting that these drugs might act as mild anticoagulants, may explain, at least in part, the therapeutic benefits observed in a wide spectrum of patients with varying cholesterol levels, including subjects with acute coronary events. The HMG-CoA reductase inhibitors (statins) have been shown to exhibit several vascular protective effects, including antithrombotic properties, that are not related to changes in lipid profile. Treatment with statins can lead to a significant downregulation of the blood coagulation cascade, most probably as a result of decreased tissue factor expression, which leads to reduced thrombin generation.
- Published
- 2005
- Full Text
- View/download PDF
17. The dynamics of thrombin formation.
- Author
-
Mann KG, Butenas S, and Brummel K
- Subjects
- Animals, Blood Coagulation Factor Inhibitors physiology, Blood Coagulation Factors physiology, Hemostasis physiology, Humans, Models, Biological, Thrombin physiology, Thromboplastin metabolism, Thromboplastin physiology, Thrombin biosynthesis
- Abstract
The central event of the hemostatic process is the generation of thrombin through the tissue factor pathway. This is a highly regulated, dynamic process in which thrombin itself plays many roles, positively and negatively its production and destruction. The hemostatic process is essential to normal physiology and is also the Achilles heel of our aging population. The inappropriate generation of thrombin may lead to vascular occlusion with the consequence of myocardial infarction, stroke, pulmonary embolism, or venous thrombosis. In this review, we summarize our present views regarding the tissue factor pathway by which thrombin is generated and the roles played by extrinsic and intrinsic factor Xa generating complexes in hemostasis and the roles of the stoichiometric and dynamic inhibitors that regulate thrombin generation.
- Published
- 2003
- Full Text
- View/download PDF
18. Influence of factor VIIa and phospholipids on coagulation in "acquired" hemophilia.
- Author
-
Butenas S, Brummel KE, Paradis SG, and Mann KG
- Subjects
- Blood Donors, Blood Substitutes chemistry, Blood Substitutes metabolism, Factor VIIa metabolism, Fibrinogen metabolism, Humans, Phosphatidylcholines blood, Phosphatidylcholines physiology, Phosphatidylserines blood, Phosphatidylserines physiology, Phospholipids blood, Phospholipids chemistry, Recombinant Proteins blood, Thrombin biosynthesis, Thromboplastin physiology, Titrimetry methods, Whole Blood Coagulation Time, Blood Coagulation physiology, Factor VIIa physiology, Hemophilia B blood, Phospholipids physiology
- Abstract
Objective: This study was performed to evaluate the influences of phospholipids and recombinant factor VIIa (rFVIIa) on thrombin generation and clot formation in "acquired" hemophilia B., Methods and Results: A synthetic mixture corresponding to hemophilia A (SHA) and "acquired" hemophilia B blood (AHBB) manufactured in vitro by an anti-FIX antibody were used in this study. With 10 pmol/L tissue factor (TF), 10 nmol/L rFVIIa, and saturating phospholipid, established thrombin generation in SHA was similar to that observed in the presence of factor VIII and rFVIIa at physiological concentrations. At lower phospholipid concentrations, thrombin generation was delayed and reduced. With 5 pmol/L TF, contact pathway-inhibited AHBB clotted later than normal blood and showed reduced clot stability and thrombin generation. These parameters of effectiveness were increased by the addition of phospholipids to AHBB, which restored clot stability and increased thrombin generation. No correction of clot formation or thrombin generation was observed when rFVIIa and phospholipids were added to AHBB in the absence of TF., Conclusions: The influence of rFVIIa is dependent on TF, and phospholipids substantially increase the hemostatic (or thrombotic) potential of rFVIIa/TF.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.